Cargando…
The Use Of Oral Ranolazine To Convert New Or Paroxysmal Atrial Fibrillation: A Review Of Experience With Implications For Possible "Pill In The Pocket" Approach To Atrial Fibrillation
BACKGROUND: Atrial fibrillation (AF) is the most common arrhythmia requiring treatment. High dose oral anti-arrhythmics may cardiovert some paroxysmal AF. This "pill in pocket" approach has allowed patients to treat themselves on an as needed basis. Pro-arrhythmic concerns have limited the...
Autores principales: | Murdock, David K, Kersten, Mary, Kaliebe, Jeff, Larrain, German |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Indian Heart Rhythm Society
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735158/ https://www.ncbi.nlm.nih.gov/pubmed/19763194 |
Ejemplares similares
-
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation
por: Murdock, David K, et al.
Publicado: (2008) -
A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation
por: Aizawa, Yoshiyasu, et al.
Publicado: (2010) -
Refractory atrial fibrillation effectively treated with ranolazine
por: Vaishnav, Aditi, et al.
Publicado: (2014) -
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023) -
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation
por: Verrier, Richard L., et al.
Publicado: (2013)